Protocol for the melatools skin selfmonitoring trial: A phase II randomised controlled trial of an intervention for primary care patients at higher risk of melanoma

K Mills; J Emery; R Lantaff; M Radford; M Pannebakker; P Hall; N Burrows; K Williams; CL Saunders; P Murchie; FM Walter

Journal article

Protocol for the melatools skin selfmonitoring trial: A phase II randomised controlled trial of an intervention for primary care patients at higher risk of melanoma

K Mills, J Emery, R Lantaff, M Radford, M Pannebakker, P Hall, N Burrows, K Williams, CL Saunders, P Murchie, FM Walter

BMJ Open | BMJ PUBLISHING GROUP | Published : 2017

DOI: 10.1136/bmjopen-2017-017934

Download PDF

Abstract

Introduction Melanoma is the fifth most common cancer in the UK. Incidence rates have quadrupled over the last 30 years and continue to rise, especially among younger people. As routine screening of the general population is not currently recommended in the UK, a focus on secondary prevention through early detection and prompt treatment in individuals at increased risk of melanoma could make an important contribution to improve melanoma outcomes. This paper describes the protocol for a phase II, multisite, randomised controlled trial, in the primary care setting, for patients at increased risk of melanoma. A skin self-monitoring (SSM) smartphone 'App' was used to improve symptom appraisal an..

View full abstract

University of Melbourne Researchers

Jon Emery Author

Grants

Awarded by National Institute on Handicapped Research

Funding Acknowledgements

This study is supported by the UK Clinical Research Collaboration-registered King's Clinical Trials Unit at King's Health Partners, which is part-funded by the NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and King's College London and the NIHR Evaluation, Trials and Studies Coordinating Centre. This work was also supported by FMW's Clinician Scientist award (RG 68235) from the National Institute for Health Research (NIHR). The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health. The paper also presents independent research funded/supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care (CLAHRC) East of England, at Cambridgeshire and Peterborough NHS Foundation Trust.